查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1495406

固態器官移植排斥市場：按交付項目、器官類型、排斥類型、最終用戶分類 - 全球預測 2024-2030

Solid Organ Transplantation Rejection Market by Offering (Diagnosis & Testing Solutions, Medications), Organ Type (Heart, Kidneys, Liver), Rejection Type, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

固態器官移植排斥市場規模預估2023年為77.9億美元，2024年達81.5億美元，2030年達108.9億美元，預估複合年增率為4.90%。

固態器官移植涉及肺、心臟、腎臟和肝臟等重要器官的替代，可顯著提高患者的生存率和生活品質。固態器官移植排斥是受者免疫系統將移植器官識別為異物並對固態器官造成損害的過程，需要藥物治療和治療。全球遭受器官衰竭的人數正在增加，這主要是由於慢性病、老齡化和生活方式因素造成的。隨著器官移植需求的增加，對有效排斥管理解決方案的需求也增加。器官移植的增加將推動市場成長。此外，公眾和專業人士對固態器官移植進步和排斥管理技術改進的認知的提高也對市場成長做出了重大貢獻。然而，固態器官移植涉及複雜且昂貴的醫療程序，例如移植前篩檢、手術本身、術後護理以及持續的免疫抑制治療，導致費用高昂，尤其是在低度開發地區，患者可能會面臨高昂的費用。改進的免疫抑制治療方法的不斷開拓提供了透過降低移植後器官排斥的發生率來擴大市場的機會。

主要市場統計
基準年[2023] 77.9億美元
預測年份 [2024] 81.5億美元
預測年份 [2030] 108.9億美元
複合年成長率（%） 4.90%

區域洞察

美洲地區，尤其是美國，由於醫療設施先進、醫療體系發達，器官移植的普及很高。該地區擁有強大的器官移植網路和大量的移植手術，因此對抗排斥藥物和治療的需求很高。這些產品對於抑制移植器官的免疫反應至關重要。由於強力的監管支持和大量的醫療保健支出，美國在採用新的先進治療方法方面也處於領先地位。亞太地區顯示固態器官移植排斥市場的成長。這是由於醫療基礎設施的增加、治療成本降低而導致的醫療旅遊業的增加以及對移植作為慢性病的可行選擇的認知的提高所推動的。印度和中國等國家的移植數量正在增加。由於器官移植手術數量的增加以及對移植排斥的認知不斷增強，歐洲、中東和非洲地區的固態移植排斥干預市場呈現顯著成長。歐洲擁有完善的醫療保健體系和完善的法律規範。受醫療基礎設施改善和移植計畫國際合作的影響，中東和非洲正在經歷適度成長。

FPNV定位矩陣

FPNV 定位矩陣對於評估固態器官移植排斥市場供應商的定位至關重要。此矩陣提供了對供應商的全面評估，並檢驗了與商務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估，供應商被分為代表其成功程度的四個像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對固態器官移植排斥市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻，您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外，該分析還提供了對該行業競爭性質的寶貴見解，包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並製定有效的策略，以在市場競爭中保持領先地位。

策略分析與建議

策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對固態器官移植排斥市場當前地位的全面評估使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析，以確定核心優勢和需要改進的領域。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地的器官移植數量正在增加。
      • 人們越來越認知到移植和排斥反應管理的進步
    • 抑制因素
      • 移植手術相關的高費用
    • 機會
      • 免疫抑制治療和監測技術的進展
      • 基因測試的出現提高了排斥風險的準確預測
    • 任務
      • 與免疫抑制治療相關的複雜性
  • 市場區隔分析
    • 提議：治療移植器官排斥的藥物需求增加
    • 最終使用者：固態器官移植排斥反應廣泛應用於醫院管理
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章固態器官移植拒絕市場：依報價

  • 診斷和測試解決方案
  • 藥品

第7章依器官類型固態的實體器官移植排斥市場

  • 心
  • 腎
  • 肝
  • 肺
  • 胰臟

第8章固態器官移植排斥反應市場（依排斥類型）

  • 急性排斥反應
  • 慢性排斥反應
  • 超急性排斥反應

第9章固態器官移植排斥市場：依最終用戶分類

  • 醫院
  • 專科診所

第10章美洲固態器官移植排斥市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太固態器官移植排斥市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲固態器官移植排斥市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 開創性合作旨在預防器官移植排斥取得突破
    • 移植後監測新進展：即時電子器官健康追蹤器
    • GenDx 獲得都靈大學 cfDNA 檢測許可，以加強肺移植監測
  • 戰略分析和建議

第14章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-CB04E05661AD

[181 Pages Report] The Solid Organ Transplantation Rejection Market size was estimated at USD 7.79 billion in 2023 and expected to reach USD 8.15 billion in 2024, at a CAGR 4.90% to reach USD 10.89 billion by 2030.

Solid organ transplantation, encompassing the replacement of vital organs, including the lungs, heart, kidneys, or liver, markedly improves patient survival and quality of life. Solid organ transplantation rejection is a process in which a recipient's immune system identifies the transplanted organ as foreign and causes damage to the transplanted organ, creating the need for solid organ transplantation rejection medications and therapies. There is a rising number of individuals worldwide who suffer from organ failures, primarily due to chronic diseases, aging, and lifestyle factors. As the demand for organ transplants increases, the requirement for effective rejection management solutions also increases. This rise in organ transplantation propels the market growth. In addition, the rising public and professional awareness of advancements in solid organ transplantation and improved rejection management techniques significantly contribute to market growth. However, solid organ transplantation involves complex and costly medical procedures, including pre-transplant screenings, the surgery itself, post-operative care, and ongoing immunosuppression treatments, which require high costs and can be a significant barrier to market growth, as they may limit transplantation's accessibility for patients and strain healthcare budgets, particularly in less economically developed regions. The ongoing development of refined immunosuppressive treatments offers the opportunity for market expansion by reducing the incidence of organ rejection post-transplant.

KEY MARKET STATISTICS
Base Year [2023] USD 7.79 billion
Estimated Year [2024] USD 8.15 billion
Forecast Year [2030] USD 10.89 billion
CAGR (%) 4.90%

Regional Insights

In the Americas, particularly the United States, there is a high prevalence of organ transplants due to advanced medical facilities and a well-structured healthcare system. This region has a robust organ transplantation network and showcases a significant number of transplant procedures, leading to a substantial need for anti-rejection drugs and therapies. These products are essential to help in reducing the immune response against transplanted organs. The U.S. also leads in adopting new and advanced therapies due to strong regulatory support and substantial healthcare spending. The Asia-Pacific region is showcasing growth in the solid organ transplant rejection market, propelled by increasing healthcare infrastructure, rising medical tourism due to lower treatment costs, and growing awareness about transplantation as a viable option for chronic diseases. Countries, including India and China are seeing increased numbers of transplantations. The market for solid organ transplant rejection interventions in the EMEA region showcases significant growth due to increasing organ transplant procedures and heightened awareness about transplant rejection. Europe has well-established healthcare systems and supportive regulatory frameworks. The Middle East and Africa are witnessing gradual growth, influenced by improving healthcare infrastructure and international collaborations for transplant programs.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Solid Organ Transplantation Rejection Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Growing number of organ transplants worldwide
      • Rising awareness about the advancements in transplantation and rejection management
    • Market Restraints
      • High costs associated with transplantation procedures
    • Market Opportunities
      • Advancements in immunosuppressive treatments and monitoring technologies
      • Emergence of genetic testing to improve predicting rejection risks accurately
    • Market Challenges
      • Complexities associated with immunosuppressive therapies
  • Market Segmentation Analysis
    • Offering: Increasing need for medication to treat the rejection of the transplanted organ
    • End-User: Extensive use in hospitals for managing solid organ transplantation rejection
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Solid Organ Transplantation Rejection Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Solid Organ Transplantation Rejection Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Pioneering Partnership Targets Breakthrough in Organ Transplant Rejection Prevention

Taiwan Bio and TRACT Therapeutics collaborated on cutting-edge cellular therapy aimed at transforming the prevention of allograft rejection in solid organ transplants. This new alliance enhanced a Phase 2 clinical trial across multiple centers in the U.S. and Taiwan, focusing on decreasing the reliance on immunosuppressant drugs in recipients of kidney transplants from living donors. Combining Taiwan Bio's expertise in cellular therapy manufacturing with TRACT Therapeutics' innovative regulatory T-cell therapy platform, this partnership aims to significantly enhance transplant outcomes while improving patients' quality of life. [Published On: 2023-12-06]

New Development in Post-Transplant Monitoring: Real-Time Electronic Organ Health Tracker

Researchers at Northwestern University innovated the first electronic device designed for continuous, real-time health monitoring of transplanted organs. This study introduces a novel, ultrathin sensor that sits atop transplanted kidneys to monitor for temperature anomalies indicative of inflammation or other complications, which could signal rejection. The device enhances patient safety by wirelessly transmitting data directly to healthcare providers via smartphone or tablet, ensuring immediate medical response to potential issues. [Published On: 2023-09-08]

GenDx Acquires Licensing for cfDNA Assay from Torino University to Enhance Lung Transplant Monitoring

GenDx, a Dutch company, has obtained exclusive licensing rights for a cell-free DNA (cfDNA) assay from Torino University. This innovative diagnostic tool is specifically designed to detect and monitor organ rejection in lung transplant recipients. The cfDNA assay offers a non-invasive method to identify early signs of rejection, which is crucial for the timely intervention and management of transplant patients. This advancement promises to enhance post-transplant care by facilitating continuous monitoring and potentially improving patient outcomes. [Published On: 2023-05-25]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Solid Organ Transplantation Rejection Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Solid Organ Transplantation Rejection Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accord Healthcare Limited, Asahi Kasei Corporation, Astellas Pharma Inc., Biocon, Cipla Ltd., Dr. Reddy's Laboratories Ltd., Eris Lifesciences Ltd., Eurofins Transplant Diagnostics, F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Globela Pharma, Lupin Limited, Manus Aktteva Biopharma LLP, Natco Pharma Ltd., Novartis AG, Panacea Biotec Pharma Ltd., Pfizer Inc., Plexision, Sanofi S.A., SAS Alsachim by Shimadzu Group, Strides Pharma Global Pte Ltd., Teva Pharmaceuticals Inc., Thermo Fisher Scientific Inc., Veloxis Pharmaceuticals A/S, and Zydus Lifesciences Limited.

Market Segmentation & Coverage

This research report categorizes the Solid Organ Transplantation Rejection Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Offering
    • Diagnosis & Testing Solutions
      • Biopsy
      • Blood Tests
      • Imaging Tests
    • Medications
      • Antibodies
      • Antimetabolites
      • Calcineurin Inhibitors
      • Steroids
  • Organ Type
    • Heart
    • Kidneys
    • Liver
    • Lungs
    • Pancreas
  • Rejection Type
    • Acute Rejection
    • Chronic Rejection
    • Hyperacute Rejection
  • End-User
    • Hospitals
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing number of organ transplants worldwide
      • 5.1.1.2. Rising awareness about the advancements in transplantation and rejection management
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with transplantation procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in immunosuppressive treatments and monitoring technologies
      • 5.1.3.2. Emergence of genetic testing to improve predicting rejection risks accurately
    • 5.1.4. Challenges
      • 5.1.4.1. Complexities associated with immunosuppressive therapies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Offering: Increasing need for medication to treat the rejection of the transplanted organ
    • 5.2.2. End-User: Extensive use in hospitals for managing solid organ transplantation rejection
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Solid Organ Transplantation Rejection Market, by Offering

  • 6.1. Introduction
  • 6.2. Diagnosis & Testing Solutions
  • 6.3. Medications

7. Solid Organ Transplantation Rejection Market, by Organ Type

  • 7.1. Introduction
  • 7.2. Heart
  • 7.3. Kidneys
  • 7.4. Liver
  • 7.5. Lungs
  • 7.6. Pancreas

8. Solid Organ Transplantation Rejection Market, by Rejection Type

  • 8.1. Introduction
  • 8.2. Acute Rejection
  • 8.3. Chronic Rejection
  • 8.4. Hyperacute Rejection

9. Solid Organ Transplantation Rejection Market, by End-User

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Specialty Clinics

10. Americas Solid Organ Transplantation Rejection Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Solid Organ Transplantation Rejection Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Solid Organ Transplantation Rejection Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Pioneering Partnership Targets Breakthrough in Organ Transplant Rejection Prevention
    • 13.3.2. New Development in Post-Transplant Monitoring: Real-Time Electronic Organ Health Tracker
    • 13.3.3. GenDx Acquires Licensing for cfDNA Assay from Torino University to Enhance Lung Transplant Monitoring
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. SOLID ORGAN TRANSPLANTATION REJECTION MARKET RESEARCH PROCESS
  • FIGURE 2. SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. SOLID ORGAN TRANSPLANTATION REJECTION MARKET DYNAMICS
  • FIGURE 7. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. SOLID ORGAN TRANSPLANTATION REJECTION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. SOLID ORGAN TRANSPLANTATION REJECTION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SOLID ORGAN TRANSPLANTATION REJECTION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY BIOPSY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY BIOPSY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY BLOOD TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY IMAGING TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ANTIMETABOLITES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ANTIMETABOLITES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY STEROIDS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY STEROIDS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY HEART, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY HEART, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY KIDNEYS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY KIDNEYS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY LIVER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY LIVER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY LUNGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY LUNGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY PANCREAS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY PANCREAS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ACUTE REJECTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ACUTE REJECTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY CHRONIC REJECTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY CHRONIC REJECTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY HYPERACUTE REJECTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY HYPERACUTE REJECTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 73. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 74. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 82. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 83. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 84. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 85. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 86. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 91. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 94. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 95. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 96. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 97. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 98. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 101. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 102. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 103. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 106. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 107. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 108. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 109. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 110. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 111. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 112. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 113. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 114. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 115. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 118. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 119. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 120. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 121. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 122. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 125. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 126. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 127. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 130. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 131. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 132. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 148. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 150. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 152. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 154. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 158. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 159. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 160. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 161. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 162. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 163. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 164. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 165. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 168. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 169. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 170. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 171. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 172. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 173. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 174. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 175. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 176. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 177. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 180. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 181. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 182. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 183. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 184. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 185. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 186. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 187. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 188. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 189. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 192. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 193. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 194. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 195. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 196. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 197. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 198. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 199. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 200. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 201. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 204. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 205. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 206. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 207. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 208. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 209. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 210. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 211. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 212. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 213. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 216. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 217. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 218. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 219. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 220. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 221. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 222. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 223. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 224. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 225. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 228. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 229. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 230. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 231. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 232. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 233. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 234. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 235. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 236. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 237. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 240. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 241. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 242. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 255. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 256. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 257. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 258. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 259. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 260. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 261. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 264. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 265. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 266. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 267. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 268. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 269. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 270. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 271. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 272. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 273. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 276. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 277. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 278. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 279. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 280. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 281. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 282. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 283. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 284. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 285. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 288. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 289. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLIO